SB-007, we’ve been expecting you
Introducing Splice Bio, a genetic medicines company with some exciting developments for Stargardt’s patients.
Search
Search results
Meet our Trustee: Dr Samuel Godfrey
Sam joins Retina UK, bringing a blend of scientific expertise, strategic leadership, and communication experience gained from over a decade working at Cancer Research UK.
e-Newsletter June 2023
Our monthly e-Newsletter featuring the latest updates from Retina UK. Subscribe now to receive these updates directly to your email.
50th Anniversary Gala Dinner 2026
It’s time to reflect, celebrate and look to the future... and you’re invited. Join us for an unforgettable evening as we celebrate the culmination of our 50th anniversary year.
Tribute to Retina UK founder Lynda Cantor MBE
Tribute to Retina UK founder Lynda Cantor MBE
e-Newsletter May 2024
Our monthly e-Newsletter featuring the latest updates from Retina UK.
Belite Bio announces promising phase 3 results for Stargardt disease
The latest research news from Retina UK.
e-Newsletter July 2025
Our monthly e-Newsletter featuring the latest updates from Retina UK.
Exciting developments for new treatment research
In recent years there has, understandably, been a lot of excitement around cutting-edge therapies that target the specific genetic faults underlying inherited sight loss.
Look Forward – Summer 2025 – Issue 186
This edition marks the start of the charity's 50th anniversary year. It includes lots of ways to get involved over the next 12 months along with details of our Annual and Professionals' Conferences in September.